Pentose Phosphate Pathway Inhibition activates Macrophages towards phagocytic Lymphoma Cell Clearance
Beielstein, A. C.; Izquierdo, E.; Blakemore, S. J.; Nickel, N.; Michalik, M.; Chawan, S.; Brinker, R.; Bartel, H.-H.; Vorholt, D.; Nolte, J. L.; Linke, R.; Costa Picosi, C. R.; Saiz, J.; Picard, F.; Meinel, J.; Buettner, R.; Villasenor, A.; Winkels, H.; Hallek, M.; Krueger, M.; Barbas, C.; Pallasch, C. P.
Show abstract
Macrophages in the B-cell lymphoma microenvironment represent a functional node in progression and therapeutic response. We assessed metabolic regulation of macrophages in the context of therapeutic antibody-mediated phagocytosis. Pentose phosphate pathway (PPP) inhibition by specific compounds and shRNA targeting induced increased phagocytic lymphoma cell clearance. Moreover, macrophages provided decreased support for survival of lymphoma cells. PPP inhibition induced metabolic activation, cytoskeletal re-modelling and pro-inflammatory polarization of macrophages. A link between PPP and immune regulation was identified as mechanism of macrophage repolarization. Inhibition of the PPP causes suppression of glycogen synthesis and subsequent modulation of the immune modulatory UDPG-Stat1-Irg1-Itaconate axis. PPP inhibition rewired macrophage maturation and activation in vivo. Addition of the PPP inhibitor S3 to antibody therapy achieved significantly prolonged overall survival in an aggressive B-cell lymphoma mouse model. We hypothesize the PPP as key regulator and targetable modulator of macrophage activity in lymphoma to improve efficacy of immunotherapies. HighlightsO_LIMacrophage-mediated lymphoma cell phagocytosis is increased by pentose phosphate pathway (PPP) inhibition as an immune regulatory switch for macrophage function and polarization C_LIO_LIPPP inhibition is linked to decreased glycogen synthesis and subsequent modulation of the UDPG-Stat1-Irg1-Itaconate axis C_LIO_LIPPP inhibition is tolerable in vivo and facilitates therapeutic targeting of B-cell lymphoma C_LI
Matching journals
The top 14 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Methylmalonic acid induces metabolic abnormalities and exhaustion in CD8+ T cells to suppress anti-tumor immunity 95%
- Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition 93%
- Repurposing screen identifies Amlodipine as an inducer of PD-L1 degradation and antitumor immunity 92%
Similar papers in this journal
- Inhibition of Acyl-CoA Synthetase Long Chain Isozymes Decreases Multiple Myeloma Cell Proliferation and Causes Mitochondrial Dysfunction 93%
- RASSF1A independence and early Galectin-1 upregulation in PIK3CA induced hepatocarcinogenesis: new therapeutic venues 92%
- Expression and DNA methylation of 20S proteasome subunits as prognostic and resistance markers in cancer 92%
Similar papers in this journal
- Metabolic Adaptations To Acute Glucose Uptake Inhibition Converge Upon Mitochondrial Respiration For Leukemia Cell Survival 93%
- Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancer 93%
- PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma 92%
Similar papers in this journal
- Single-cell transcriptome analysis of the immunosuppressive effect of differential expression of tumor PD-L1 on responding TCR-T cells 93%
- Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition 92%
- Interleukin-22 drives a metabolic adaptive reprogramming to maintain mitochondrial fitness and treat liver injury 91%